Type 111 protein S deficiency is characterized by a low plasma level of free protein S, whereas the total concentration of protein S is normal. In contrast, both free and total protein S levels are low in type I deficiency. To elucidate the molecular mechanism behind the selective deficiency of free protein S in type 111 deficiency, the relationship between the plasma concentrations of P-chain containing isoforms of C4b-binding protein (C4BPP+) and different forms of protein S (free, bound, and total) was evaluated in 327 members of 18 protein S-deficient families. In normal relatives (n = 1901, protein S correlated well with C4BPP+, with free protein S (96 f 23 nmol/L) being equal to the molar excess of protein S (355 f 65 nmol/L) over C4BPP+ (275 r 47 nmol/L). In protein S-deficient family members (n = 117). the equimolar relationship between protein S (215 k 50 nmol/L) and C4BPP+ (228 +. 51 nmol/L), together with the high affinity of the interaction, resulted in low levels of free protein S (16 f 10 nmol/L). Free protein S levels were distinctly low in protein ROTEIN S IS A VITAMIN K-dependent plasma protein with important anticoagulant properties." Although its mechanism of action is not fully understood, its main activity appears to be as that of a cofactor to activated protein C (APC) in the degradation of the activated forms of factors V and VI11 (Va and VIIIa). The APC-cofactor activity of protein S, which is weak in purified systems, was recently found to be potentiated by factor V but not by factor Va.' Hereditary protein S deficiency is associated with an increased risk of thromboembolic disease.'"' Acquired protein S deficiency may be the result of oral anticoagulant therapy, liver disease, nephrotic syndrome, disseminated intravascular coagulation, or pregnan~y.'~.'~ Protein S deficiency is found in a small proportion (1.5% to 7 % ) of patients with thromboembolic disease."-" Protein S exists in two forms in human plasma, as free protein (30% to 40%) and as part of a bimolecular, noncovalent complex, the interacting protein being C4b-binding protein (C4BP)," which is a regulator of the classical complement pathway." C4BP is composed of 6 or 7 a-chains and I or no P-chain. Different C4BP isoforms are present in plasma, but only P-chain containing C4BP (C4BPP+) binds protein S, with the protein S binding site being located on the p
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with important anticoagulant properties." Although its mechanism of action is not fully understood, its main activity appears to be as that of a cofactor to activated protein C (APC) in the degradation of the activated forms of factors V and VI11 (Va and VIIIa). The APC-cofactor activity of protein S, which is weak in purified systems, was recently found to be potentiated by factor V but not by factor Va.' Hereditary protein S deficiency is associated with an increased risk of thromboembolic disease.'"' Acquired protein S deficiency may be the result of oral anticoagulant therapy, liver disease, nephrotic syndrome, disseminated intravascular coagulation, or pregnan~y.'~.'~ Protein S deficiency is found in a small proportion (1.5% to 7 % ) of patients with thromboembolic disease."-" Protein S exists in two forms in human plasma, as free protein (30% to 40%) and as part of a bimolecular, noncovalent complex, the interacting protein being C4b-binding protein (C4BP)," which is a regulator of the classical complement pathway." C4BP is composed of 6 or 7 a-chains and I or no P-chain. Different C4BP isoforms are present in S-deficient members, whereas in 47 of the protein S-deficient individuals, the concentration of total protein S was within the normal range, which fulfils the criteria for type 111 deficiency. The remaining 70 had low levels of both total and free protein S and, accordingly, would be type I deficient.
Coexistence of type I and type 111 deficiency was found in 14 families, suggesting the two types of protein S deficiency t o be phenotypic variants of the same genetic disease. Interestingly, not only protein S but also C4BPP+ levels were decreased in orally anticoagulated controls and even more so in anticoagulated protein S-deficient members, suggesting that the concentration of C4BPP+ is influenced by that of protein S. In conclusion, our results indicate that type I and type 111 deficiencies are phenotypic variants of the same genetic disease and that the low plasma concentrations of free protein S in both types are the result of an equimolar relationship between protein S and C4BPp+.
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The protein S-C4BP interaction is of high affinity and the equilibrium is shifted towards complex formation in vivo." Because only free protein S is active as APC-cofactor,8~"'.3h it is crucially important that its plasma concentration is carefully regulated." The mechanisms by which this is achieved are not fully understood. In healthy individuals, the concentration of free protein S is determined by the molar concentrations of protein S and C4BPP+, with free protein S being equal to the molar surplus of protein S over C4BPP+.78 This finding holds true also during the acute-phase response, during which the a-and P-chains are differentially regulated." The balance between the concentrations of C4BPP+ and total protein S remains during the acute phase and, as a consequence, the levels of free protein S are stable. This finding suggests that the concentrations of protein S and C4BPP+ are the only parameters that determine the concentration of free protein S.
Three different types of protein S deficiency have been described." According to the nomenclature proposed by Bertina at the ISTH subcommittee meeting in 199 1, type I deficiency is characterized by a parallel decrease in both total and free protein S.6,8,9.'2.15 In type I1 deficiency, the functional protein S activity is decreased, whereas the levels of total and free protein S are n~r m a l .~" .~' Type I11 deficiency is characterized by normal concentrations of total protein S but IOW levels of free protein S.s.'"42-45 It was recently shown that many of the reported type I1 deficiency cases do not suffer from protein S gene defects and that the condition is caused by APC resistance." ' To elucidate the molecular mechanism of the selectively decreased levels of free protein S in type I11 protein S deficiency, plasma concentrations of C4BP isoforms and protein S were determined in both type I and type 111 protein S deficiency. The two types of protein S deficiency were found to be phenotypic variants of the same genetic disease and the low free protein S to be the result of an equimolar relationship between protein S and C4BPP+. 
PATIENTS AND METHODS
Putienrs. All participants gave informed consent and the study was approved by the medical ethics committee at the University of Lund. Patients were selected from the files of the Department of Coagulation Disorders, Malmo General Hospital. When the study began, 20 families with inherited deficiency of protein S were known. The diagnosis of protein S deficiency was based on free protein S antigen levels less than the normal reference range (56 to 182 nmoVL) combined with low or normal total protein S (normal range, 219 to 407 nmoVL). In patients on stable warfarin treatment, diagnosis was based on free protein S levels less than the lower range observed in an anticoagulated control group (16 to 91 nmoV L) combined with total protein S levels less than or within the range observed in anticoagulated controls (156 to 322 nmoVL). Eighteen of the 20 probands had had one or more of the following venous thrombotic events: deep venous thrombosis (n = IS), pulmonary emboli (n = 4), superficial thrombophlebitis (n = 7), and mesentera1 vein thrombosis (n = 2). The mean age at the first episode was 27 years (range, 14 to 46 years). A history of arterial thrombosis was found in two probands; one had suffered a stroke at 53 years of age and the other had bilateral thrombosis of the popliteal arteries at age 56 years. One of the probands had not had thrombosis and was referred because of familial thrombophilia. One proband was deceased but his relatives volunteered to participate. The remaining probands were 7 women and 12 men. After pedigree analysis, two plus two families turned out to be related, which reduced the number of unrelated families to 18. Totally, 308 relatives were studied; the mean age of all 327 individuals was 37.5 years (range, 6 to 88 years).
The investigated subjects answered a questionnaire about their medical history that emphasized manifestations of deep venous thrombosis, pulmonary embolism, superficial thrombosis, and arterial thrombosis. Patients with thrombosis were interviewed by a physician and/or medical records were studied. The term deep venous thrombosis refers to deep leg vein thrombosis as well as to thrombosis at unusual locations such as the axillary, mesenteric, and cerebral veins. Thrombotic event refers to deep venous thrombosis, pulmonary embolism, or superficial thrombophlebitis. Only thrombotic episodes established by a physician on the basis of objective means or by physical examination were considered thrombotic events; 54 (69%) of the 78 symptomatic patients had had a thrombotic event diagnosed by an objective method. In 20 family members, protein S levels were measured during stable anticoagulant treatment only.
Of the 136 protein S-deficient patients, 64 (47%) had had one or more venous thrombotic events as compared with 14 (7%) of the normal relatives (n = 191). The clinical manifestations are presented in further detail elsewhere.46" Controls. The healthy control group was composed of 60 volunteers. Outpatients (n = 40; mean age, 68 2 13 years) on stable long-term oral anticoagulant treatment served as the anticoagulated control group. Seven of these individuals had had a venous thromboembolic event not related to protein S deficiency, and the remaining 33 had disorders unrelated to venous thromboembolism.
Laboruroory methods. Blood sampling and routine coagulation methods were performed as de~cribed.~' Protein S was measured with a radioimmunoassay as previously described." The amount of free protein S was determined in 5% PEG 6000 supernatants, using a pool of normal plasmas as contr01.'~ The amount of bound protein S was calculated as the difference between total and free protein S." Total C4BP (C4BPt) and C4BPP+ plasma levels were measured with previously described enzyme-linked immunosorbent assay (ELISA) methods" with the following modification: a polyclonal antibody against plasma purified C4BP was used as catching antibody (coated at a concentration of 50 #g/mL) instead of the polyclonal antiserum against C4BP tentacles."
The following extinction coefficients were used: C4BPt, 14.14'; C4BPP+, 13.639; and protein S, 9.5.48 Proteins used as standards have been described p r e v i o~s l y .~~ The molecular weights used for molarity calculations were 75,000 for protein S and 570,000 for C4BP.
Srurisricul methods. All data were expressed as mean 2 standard deviation (SD); n equals the number of samples in each group.
Calculations of Pearsson's correlation coefficient (r), probability (P), and comparison by the Student's r-test were performed with Statview SE + Graphics software (Abacus Concepts, Inc. Berkeley, CA). P < .05 was considered significant.
RESULTS
Type I and type I l l dejiciencies as phenotypic variants of the same genetic disease. A total of 327 family members (177 women and 150 men) from 18 unrelated families with inherited protein S deficiency were investigated. The protein S-deficient family members were best identified from measurements of free protein S because there was a clear demarcation zone between protein S-deficient and normal members in 17 of the 18 families (Fig 1) . Low levels of free protein S (<56 nmoVL) were found in 117 (49 men and 68 women) of 307 nonanticoagulated family members, with the remaining 190 (89 men and 101 women) having normal levels of free protein S (Figs 1 and 2 ). Decreased levels of total protein S were found in 70 of the cases with free protein S deficiency (fulfilling criteria for type I deficiency), whereas the remaining 47 patients had total protein S concentration within the reference range (fulfilling criteria for type I11 deficiency). If diagnosis of protein S deficiency was to be based only on the concentration of total protein S, 40% of protein S-deficient family members would have been classified as normal. In family 18, protein S-deficient members had somewhat higher mean values of both free (41 5 7 nmoVL) and total protein S (240 ? 35 nmoVL) as compared with protein S-deficient cases of the other families.
The deficiency of free protein S was inherited as an autosomal dominant trait in all families with no exception. In contrast, total protein S was an insufficient marker of the genetic disease because several type I deficient members (low total protein Snow free protein S) had inherited the disease from a parent with type I11 deficiency (normal total protein Snow free protein S). Moreover, the reverse variant of type I11 deficient children inheriting the disease from a type I deficient parent was also observed. In 14 of the 18 families, both type I and type I11 deficiencies were represented (Fig l) , suggesting the two types to be phenotypic variants of the same disease.
Deficiency of free protein S was significantly associated with an increased risk for thrombosis as shown by the thrombosis-free survival According to a Kaplan-Meier analysis there was no significant difference in thrombosisfree survival between type I and I11 deficient family members (not shown), even though 22 (31%) of the 70 type I and 23 (49%) of the 47 type 111 deficient patients had had venous thrombosis (P = .06). This difference was presumably caused by the age difference between type I and type I11 deficient family members (34 ? 15 v 46 ? 20 years, P < .001).
Equimolar concentrations of protein S and C4BPP+ in protein S deficiency resulting in low levels offfee protein S.
For In normal family members as well as in controls, protein S was in molar excess over C4BPP+ (Table l) , which agrees with the concept that free protein S equals the molar surplus of protein S over C4BP~+.'X."' In the control group. the concentrations of bound protein S and C4BPP+ were not significantly different, indicating that all protein S binding sites on C4BPP+ were occupied, whereas normal family members for unknown reasons had slightly higher C4BPP+ than bound protein S. The correlation between C4BPP+ and bound protein S was high in normal relatives and somewhat lower in protein S-deficient relatives (Table 2 and Fig 3) . In this latter group, the mean total protein S concentration was 61% of normal and the molar concentrations of protein S were not significantly different from those of C4BPP+. Because most of their protein S existed in its bound state. the free protein S levels were very low ( Table I and Fig 2) . In protein S-deficient family members, the concentrations of C4BPt and C4BPP+ were 89% and 83% of the level in their normal relatives. respectively, suggesting that the C4BP concentration is influenced by the inherited protein S deficiency. In protein S-deficient members of family 18, the mean concentration of total protein S (240 5 35 nmol/L) was slightly higher than that of C4BPP+ (221 2 3 I nmol/L), in accordance with the slightly higher levels of free protein S in this family than in the other protein S-deficient families.
Oral nr~timn~qrrlmt therapy nssocinted with low ICI~PIS of protein S nnd C4RPP+. The mean plasma concentrations of free and total protein S in the 36 family members that were treated with vitamin K-antagonists were considerably lower than corresponding concentrations of 40 unrelated anticoagulated outpatients (Table I and Fig 2) . Thirty-three of the anticoagulated family members had lower levels of free protein S (range. 0 to 13 nmol/L) than the lowest level observed in anticoagulated controls (range, 16 to 91 nmol/L) and they were therefore considered to be protein S deficient. The diagnosis was confirmed during warfarin-free intervals in 14 of the family members and by pedigree analysis in another 10 patients (not shown). In one anticoagulated family member having a free protein S level equal to the lower limit of anticoagulated controls (16 nmol/L), deficiency of free and total protein S was found during a warfarin-free interval. The remaining 2 anticoagulated relatives had free protein S levels within the range of anticoagulated controls (41 and 31 nmol/L. respectively) and they were considered not to be protein S deficient. Normal protein S was found during a warfarin-free interval in one of them. The other had never had venous thrombosis and was anticoagulated because of cardiac arrhythmia. The 34 anticoagulated protein S-deficient individuals had significantly lower concentrations than nonanticoagulated protein S-deficient relatives not 
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only of free and total protein S but also of C4BPP+ (Table  I and Fig 2) . The mean total protein S level in the anticoagulated control group was 34% lower than that of the normal control group (Table I and Fig 2) . The concentrations of C4BPt and C4BPP+ were also found to be decreased, in accordance with other reports in which C4BPt have been meatein S (free, bound. and total). C4BPt. and C4BPP+ were decreased to an even greater extent in the anticoagulated protein S-deficient patients than in the anticoagulant control group (Table I) . This difference was not caused by differences in intensity of anticoagulant therapy because no significant difference in Owren's P&P (factor II + VI1 + X ) was observed between the anticoagulated controls and anticoagulated protein S-deficient members (22% ? 5 % I' 13% ? 1 4 9 ; normal reference range. 70% to 130%: therapeutic range, 10% to 25%).
The correlation between C4BPP+ and bound protein S. which was high in normal relatives and controls. was also strong in anticoagulated controls. but weaker in protein Sdeficient relatives (Table 2 and Fig 3) . In anticoagulated protein S-deficient family members there was no correlation between C4BPP+ and bound protein S. which presumably is caused by the molar excess of C4BPP+ over bound protein S. The correlation between free and total protein S was high in healthy relatives as well as in normal and anticoagulated controls, suggesting that the total protein S levels regulate the concentration of free protein S in normal individuals also when they are anticoagulated (Table 2 and Fig 4) . The correlation between free and total protein S was weak in the protein S-deficient patients and absent in anticoagulated protein S-deficient patients.
SUred,l-!.l'l.~J.~c) It is noteworthy that the concentrations of pro-
DISCUSSION
Type I and type I11 protein S deficiencies are both characterized by low plasma concentrations of free protein S. with type I11 being distinguished from type I in having a normal level of total protein S in plasma. We now demonstrate the two types of protein S deficiency to coexist in many families with protein S deficiency and to be inherited as a single genetic trait, suggesting that they are phenotypic variations of the same genetic disease. In normal individuals. there is a high correlation between the concentrations of protein S and C4BPP+, with the level of free protein S being equal to the molar surplus of protein S over C4BPP+.'*."' From this finding it follows that essentially all C4BPP+ molecules are occupied with protein S. In protein S deficiency. the concentration of protein S is equal to or somewhat lower than that of C4BPP+. which results in low levels of free protein S. In the protein S-deficient families. the concentrations of total protein S in normal members overlapped with the concentrations in those with protein S deficiency. As a result, some protein S-deficient family members had total protein S within the normal range. a pattern characteristic of type 111 protein S deficiency. Because the concentrations of protein S and C4BPP+ correlated, family members with type 111 deficiency had slightly higher concentrations not only of protein S but also of C4RPfi+ than those with type I deficiency. The high-affinity interaction between C4BPP+ been overlooked if only total protein S had been measured. In protein S-deficient family members, the mean total protein S concentration was 61% of that of normal relatives. This finding is not inconsistent with the conclusion that protein S deficiency is caused by a defect in the protein S gene. For instance, it has been shown that a proportion of patients with heterozygous deficiency of protein C have a normal plasma c~ncentration.~' Several genetic defects have been found and characterized in protein S-deficient patients, but so far mutations have only been found in approximately 50% of the investigated case^.^"^^ In the remaining 50%, it is still possible that the protein S deficiency is caused by a defect in the protein S gene. Thus, mutations may affect the poorly characterized 5' end of the protein S gene.55 Moreover, there may be gene conversion events between the protein S gene and the homologous protein S pseudogene. However, the possibility that protein S deficiency in some families is not caused by a defect in the protein S gene cannot be ruled out. For this reason, it will be important to perform genetic linkage studies in families in whom a mutation in the protein S gene is not found. Anticoagulant therapy with vitamin K-antagonists such as warfarin inhibits the y-carboxylation of glutamic acid residues, a process that is dependent on vitamin K.57 Like the other vitamin K-dependent plasma proteins, the concentration of protein S decreases during warfarin the rap^.^,'^,'^,^^ C4BP is not a vitamin K-dependent protein, but we find its plasma concentration to decrease during warfarin therapy, an observation that is in agreement with previous reports in which the concentration of C4BP in plasma of patients under oral anticoagulation was found to be 86% to 94% of nor-
The somewhat larger decrease now observed in both C4BPt and C4BPP+ (approximately 25% reduction in plasma level) may be explained by differences in analytical methods, selection criteria, or intensity of anticoagulant treatment. The high correlation between protein S and C4BPP+ in normal patients and in anticoagulated controls shows the plasma concentrations of these two proteins to be closely regulated. The decrease in plasma concentrations of C4BPP+ during warfarin therapy, in both controls and in protein S deficiency, suggests that the C4BP concentration is affected by that of protein S rather than the reverse ( Table  1 and Fig 2) . However, a direct effect of warfarin on the ma1. 19.24.49 synthesis of C4BP cannot be ruled out. The hypothesis that protein S partly regulates the C4BPP+ concentration is in accordance with the maintained balance between protein S and C4BPP+ during the acute-phase reaction.39
In conclusion, the present results show type I and type 111 protein S deficiency to be phenotypic variants of one genetic disease and support the concept that the concentration of free protein S is determined by the molar balance between C4BP@+ and total protein S.38.39 In protein S deficiency, the low level of free protein S is the result of an equimolar relationship between C4BPP+ and protein S, which is the consequence of a reduced concentration of total protein S. These findings stress the importance of measuring free protein S in the elucidation of hereditary protein S deficiency and demonstrate that there are only two types of protein S deficiency, type I being characterized by a reduced protein S level and type I1 by a functional protein S defect.
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